
Smith & Nephew plc SNN
$ 32.13
1.76%
Annual report 2025
added 04-18-2026
Smith & Nephew plc DPO Ratio 2011-2026 | SNN
Annual DPO Ratio Smith & Nephew plc
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | 232 | 258 | 253 | 249 | 220 | 181 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 258 | 181 | 232 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B | ||
|
AdaptHealth Corp.
AHCO
|
43.9 | $ 13.02 | 1.72 % | $ 1.76 B | ||
|
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | ||
|
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | ||
|
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M | ||
|
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
286 | - | 1.37 % | $ 20.5 M | ||
|
BIOLASE
BIOL
|
66.7 | - | -13.19 % | $ 166 K | ||
|
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | ||
|
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | ||
|
Cytosorbents Corporation
CTSO
|
107 | $ 0.62 | -2.1 % | $ 38.6 M | ||
|
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | ||
|
EDAP TMS S.A.
EDAP
|
40.6 | $ 3.24 | 0.47 % | $ 121 M | ||
|
Cardiovascular Systems
CSII
|
81.8 | - | 0.15 % | $ 844 M | ||
|
ClearPoint Neuro
CLPT
|
33.2 | $ 11.1 | -5.77 % | $ 314 M | ||
|
Globus Medical
GMED
|
33.1 | $ 93.97 | -0.96 % | $ 12.7 B | ||
|
Helius Medical Technologies
HSDT
|
362 | $ 2.13 | -1.16 % | $ 1.29 M | ||
|
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
124 | - | - | $ 10.2 M | ||
|
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | ||
|
Electromed
ELMD
|
47.8 | $ 26.2 | -0.72 % | $ 221 M | ||
|
Second Sight Medical Products
EYES
|
29.6 | - | -0.97 % | $ 54.4 M | ||
|
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | ||
|
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B | ||
|
LivaNova PLC
LIVN
|
68 | $ 63.24 | -1.5 % | $ 3.45 B | ||
|
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | ||
|
LENSAR
LNSR
|
146 | $ 5.15 | 1.18 % | $ 61.6 M | ||
|
Neovasc
NVCN
|
48.6 | - | - | $ 111 M | ||
|
Pulmonx Corporation
LUNG
|
60.4 | $ 1.26 | -0.39 % | $ 51.3 M | ||
|
OrthoPediatrics Corp.
KIDS
|
79.4 | $ 15.88 | -1.91 % | $ 373 M | ||
|
Butterfly Network
BFLY
|
51.3 | $ 5.58 | 4.59 % | $ 1.18 B | ||
|
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | ||
|
Insulet Corporation
PODD
|
22.5 | $ 187.73 | -0.97 % | $ 13.2 B | ||
|
Delcath Systems
DCTH
|
56 | $ 10.82 | -0.18 % | $ 388 M | ||
|
IRIDEX Corporation
IRIX
|
71.9 | $ 1.08 | 1.89 % | $ 18.3 M | ||
|
CONMED Corporation
CNMD
|
57.3 | $ 38.44 | 0.16 % | $ 1.19 B | ||
|
Inspire Medical Systems
INSP
|
103 | $ 54.68 | -2.83 % | $ 1.61 B | ||
|
Integer Holdings Corporation
ITGR
|
28.9 | $ 84.01 | -2.32 % | $ 2.92 B | ||
|
PAVmed
PAVM
|
1.12 K | $ 8.32 | -7.56 % | $ 5.58 M | ||
|
Sintx Technologies
SINT
|
223 | $ 2.41 | -2.43 % | $ 6.68 M | ||
|
Invacare Corporation
IVC
|
75.6 | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
58.1 | $ 84.41 | 0.19 % | $ 49.4 B | ||
|
Stryker Corporation
SYK
|
70.1 | $ 329.17 | 0.51 % | $ 126 B | ||
|
MiMedx Group
MDXG
|
54.8 | $ 3.36 | -2.19 % | $ 497 M | ||
|
Tactile Systems Technology
TCMD
|
24.4 | $ 24.4 | -2.67 % | $ 558 M | ||
|
Nevro Corp.
NVRO
|
61.7 | - | - | $ 217 M |